Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lise Tarnow

Showing results (51-60 of 187) with videos related to

Pageof 19
Sort By:
Diabetes Care|January 31, 2006
Cardiac autonomic neuropathy predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathyAnne Sofie Astrup, Lise Tarnow, Peter Rossing, et al.
Journal of Hypertension|October 11, 2013
Low dose spironolactone reduces blood pressure in patients with resistant hypertension and type 2 diabetes mellitus: a double blind randomized clinical trialChristina S Oxlund, Jan E Henriksen, Lise Tarnow, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|July 9, 2013
ACE genotype, phenotype and all-cause mortality in different cohorts of patients with type 1 diabetesLouise H Færch, Anne-Sophie Sejling, Maria Lajer, et al.
Nordic Journal of Psychiatry|July 22, 2025
Flash glucose monitoring and continuous glucose monitoring among patients with coexisting diabetes and severe mental illness - a convergent mixed-methods studyAnne B Hansen, Vicki Zabell, Anette Juel, et al.
Danish Medical Journal|March 24, 2025
Diabetes and vulnerabilities in people undergoing lower-extremity amputationMartin Gillies Banke Rasmussen, Sara Fokdal Lehn, Lise Tarnow, et al.
Kidney International|August 18, 2005
Improved prognosis in type 1 diabetic patients with nephropathy: a prospective follow-up studyAnne Sofie Astrup, Lise Tarnow, Peter Rossing, et al.
Journal of Diabetes Science and Technology|March 10, 2012
Paper electrocardiograph strips may contain overlooked clinical information in screen-detected type 2 diabetes patientsJesper Fleischer, Morten Charles, Lise Tarnow, et al.
Diabetes Care|April 30, 2003
Long-term renoprotective effects of losartan in diabetic nephropathy: interaction with ACE insertion/deletion genotype?Steen Andersen, Lise Tarnow, Francois Cambien, et al.
Kidney International|June 26, 2002
Renoprotective effects of losartan in diabetic nephropathy: interaction with ACE insertion/deletion genotype?Steen Andersen, Lise Tarnow, Francois Cambien, et al.
Kidney International|July 18, 2017
Plasma high-sensitivity troponin T predicts end-stage renal disease and cardiovascular and all-cause mortality in patients with type 1 diabetes and diabetic nephropathyJulie Galsgaard, Frederik Persson, Tine Willum Hansen, et al.
Pageof 19

Showing results (51-60 of 187) with videos related to

Sort By:
Pageof 19
Diabetes Care|January 31, 2006
Cardiac autonomic neuropathy predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathyAnne Sofie Astrup, Lise Tarnow, Peter Rossing, et al.
Journal of Hypertension|October 11, 2013
Low dose spironolactone reduces blood pressure in patients with resistant hypertension and type 2 diabetes mellitus: a double blind randomized clinical trialChristina S Oxlund, Jan E Henriksen, Lise Tarnow, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|July 9, 2013
ACE genotype, phenotype and all-cause mortality in different cohorts of patients with type 1 diabetesLouise H Færch, Anne-Sophie Sejling, Maria Lajer, et al.
Nordic Journal of Psychiatry|July 22, 2025
Flash glucose monitoring and continuous glucose monitoring among patients with coexisting diabetes and severe mental illness - a convergent mixed-methods studyAnne B Hansen, Vicki Zabell, Anette Juel, et al.
Danish Medical Journal|March 24, 2025
Diabetes and vulnerabilities in people undergoing lower-extremity amputationMartin Gillies Banke Rasmussen, Sara Fokdal Lehn, Lise Tarnow, et al.
Kidney International|August 18, 2005
Improved prognosis in type 1 diabetic patients with nephropathy: a prospective follow-up studyAnne Sofie Astrup, Lise Tarnow, Peter Rossing, et al.
Journal of Diabetes Science and Technology|March 10, 2012
Paper electrocardiograph strips may contain overlooked clinical information in screen-detected type 2 diabetes patientsJesper Fleischer, Morten Charles, Lise Tarnow, et al.
Diabetes Care|April 30, 2003
Long-term renoprotective effects of losartan in diabetic nephropathy: interaction with ACE insertion/deletion genotype?Steen Andersen, Lise Tarnow, Francois Cambien, et al.
Kidney International|June 26, 2002
Renoprotective effects of losartan in diabetic nephropathy: interaction with ACE insertion/deletion genotype?Steen Andersen, Lise Tarnow, Francois Cambien, et al.
Kidney International|July 18, 2017
Plasma high-sensitivity troponin T predicts end-stage renal disease and cardiovascular and all-cause mortality in patients with type 1 diabetes and diabetic nephropathyJulie Galsgaard, Frederik Persson, Tine Willum Hansen, et al.
Pageof 19